Published in Br J Clin Pharmacol on June 01, 2013
Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy. J Biol Chem (2014) 0.86
Valsalva maneuver unveils central baroreflex dysfunction with altered blood pressure control in persons with a history of mild traumatic brain injury. BMC Neurol (2016) 0.77
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation (1996) 37.54
Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J (2009) 8.25
Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation (1980) 3.87
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol (2000) 2.89
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
EFFECTS OF BETA ADRENERGIC BLOCKADE ON THE CIRCULATION WITH PARTICULAR REFERENCE TO OBSERVATIONS IN PATIENTS WITH HYPERTROPHIC SUBAORTIC STENOSIS. Circulation (1964) 1.96
Time-domain cross-correlation baroreflex sensitivity: performance on the EUROBAVAR data set. J Hypertens (2004) 1.93
Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol (2008) 1.86
Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation (1990) 1.73
Temporal response patterns of the human sinus node to brief carotid baroreceptor stimuli. J Physiol (1976) 1.64
Baroreflex sensitivity in essential and secondary hypertension. Clin Auton Res (2002) 1.50
Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J (2008) 1.37
Time delays in the human baroreceptor reflex. J Auton Nerv Syst (1983) 1.32
Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation (1989) 1.29
A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol (1999) 1.26
Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features. Circulation (1993) 1.10
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence. Eur Heart J (2012) 1.08
Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res (1998) 1.07
Time course analysis of baroreflex sensitivity during postural stress. Am J Physiol Heart Circ Physiol (2006) 1.02
Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy. Circulation (1991) 0.99
Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol (1993) 0.99
Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol (1994) 0.96
Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy. Br Heart J (1980) 0.96
Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: a biopsy study. J Am Coll Cardiol (1983) 0.94
Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation (1989) 0.93
Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head-up tilt test. Circulation (1992) 0.90
Heart rate variability used as an arrhythmia risk stratifier after myocardial infarction. Pacing Clin Electrophysiol (1997) 0.89
Time delay of vagally mediated cardiac baroreflex response varies with autonomic cardiovascular control. J Appl Physiol (1985) (2001) 0.88
Baroreflex sensitivity measured by spectral and sequence analysis in cerebrovascular disease : methodological considerations. Clin Auton Res (2006) 0.88
Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure. J Am Coll Cardiol (2000) 0.87
Heart rate deceleration runs for postinfarction risk prediction. J Electrocardiol (2011) 0.87
Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: a longitudinal heart rate variability study. Am Heart J (1999) 0.85
Effect of beta-blockade on baroreflex sensitivity and cardiovascular autonomic function tests in patients with coronary artery disease. Eur Heart J (1994) 0.84
Reduced cardiopulmonary baroreflex sensitivity in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1998) 0.83
Sympathetic restraint of baroreflex control of heart period in normotensive and hypertensive subjects. Clin Sci (Lond) (1994) 0.82
Reversal of inappropriate peripheral vascular responses in hypertrophic cardiomyopathy. J Am Coll Cardiol (2005) 0.82
Baroreflex sensitivity as a cardiac and arrhythmia mortality risk stratifier. Pacing Clin Electrophysiol (1997) 0.82
Autonomic function in hypertrophic cardiomyopathy. Br Heart J (1993) 0.80
Hypertensive cardiac hypertrophy--is genetic variance the missing link? Br J Clin Pharmacol (1996) 0.79
Exercise in hypertrophic cardiomyopathy is associated with sympatho-adrenal imbalance. Int J Cardiol (2006) 0.79
Left ventricular mass in children and adolescents. J Am Coll Cardiol (1988) 0.79
Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system. Hypertens Res (2008) 0.78
Heart rate variability in hypertrophic obstructive cardiomyopathy: association with functional classification and left ventricular outflow gradients. Int J Cardiol (2001) 0.76
[Spectrum analysis of heart rate variability in obstructive hypertrophic myocardiopathy. Evidence of altered autonomic function]. Cardiologia (1992) 0.76
Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm (2009) 5.17
Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol (2008) 1.86
Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J (2005) 1.41
Leptin and inflammation in patients with chronic heart failure. Kardiol Pol (2010) 1.39
Association between high arterial stiffness and left ventricular filling pressures in patients with acute myocardial infarction. Pol Arch Med Wewn (2015) 1.38
How to strengthen or weaken the HRV dependence on heart rate--description of the method and its perspectives. Int J Cardiol (2013) 1.18
J-wave formation in patients with acute intracranial hypertension. J Electrocardiol (2009) 1.14
Indices of vascular stiffness and wave reflection in relation to body mass index or body fat in healthy subjects. Clin Exp Pharmacol Physiol (2007) 1.07
Heart rate asymmetry by Poincaré plots of RR intervals. Biomed Tech (Berl) (2006) 0.99
Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications. Expert Rev Cardiovasc Ther (2008) 0.94
Asymmetric properties of long-term and total heart rate variability. Med Biol Eng Comput (2011) 0.93
How to select patients who will not benefit from ICD therapy by using heart rate and its variability? Int J Cardiol (2013) 0.92
Asymmetrical properties of heart rate variability in type 1 diabetes. Clin Auton Res (2010) 0.90
Correlations between the Poincaré plot and conventional heart rate variability parameters assessed during paced breathing. J Physiol Sci (2007) 0.90
Predictive value of white blood cell count on admission for in-hospital mortality in acute stroke patients. Clin Neurol Neurosurg (2004) 0.90
[Myocarditis--the first symptom of adult Still's disease]. Kardiol Pol (2009) 0.88
Association of atrial fibrillation and focal neurologic deficits with impaired cognitive function in hospitalized patients >or=65 years of age. Am J Cardiol (2006) 0.88
Heart rate deceleration runs for postinfarction risk prediction. J Electrocardiol (2011) 0.87
New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol (2011) 0.86
Evaluation of exercise capacity with cardiopulmonary exercise testing and BNP levels in adult patients with single or systemic right ventricles. Arch Med Sci (2010) 0.85
Exercise training slows down heart rate and improves deceleration and acceleration capacity in patients with heart failure. J Electrocardiol (2012) 0.84
[Pregnancy and labour in a patient after Fontan operation - a case report]. Kardiol Pol (2003) 0.84
The plasma concentration of advanced oxidation protein products and arterial stiffness in apparently healthy adults. Free Radic Res (2007) 0.82
Exercise testing in adults after repair of aortic coarctation: evaluation of cardiopulmonary exercise capacity and B-type natriuretic protein levels. Tex Heart Inst J (2007) 0.82
Arterial stiffness, central hemodynamics and wave reflection in normal pregnancy and control nonpregnant women. Eur J Obstet Gynecol Reprod Biol (2011) 0.81
Add-on therapy with doxazosin in patients with hypertension influences arterial stiffness and albuterol-mediated arterial vasodilation. Br J Clin Pharmacol (2007) 0.81
Treatment of severe thyroid function disorders and changes in body composition. Endokrynol Pol (2016) 0.79
Evaluation of exercise capacity with cardiopulmonary exercise testing and type B natriuretic peptide concentrations in adult patients with patent atrial septal defect. Cardiology (2006) 0.79
Asymmetric features of short-term blood pressure variability. Hypertens Res (2010) 0.79
Asymmetry of the variability of heart rate and conduction time between atria and ventricles. Circ J (2013) 0.79
Pregnancy and delivery in patient after Fontan's operation due to common ventricle of left ventricular morphology. Int J Cardiol (2006) 0.78
Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system. Hypertens Res (2008) 0.78
Pulse pressure amplification in relation to body fatness. Br J Clin Pharmacol (2012) 0.78
Endothelial function and baroreflex sensitivity according to the oral glucose tolerance test in patients with coronary artery disease and normal fasting glucose levels. Clin Sci (Lond) (2005) 0.78
Adults with Ebstein's anomaly--Cardiopulmonary exercise testing and BNP levels exercise capacity and BNP in adults with Ebstein's anomaly. Int J Cardiol (2005) 0.78
Cytokines and heart rate variability in patients with chronic heart failure. Kardiol Pol (2005) 0.77
Blood pressure, left ventricular mass and function in adult patients after successful repair of coarctation of the aorta. Kardiol Pol (2003) 0.77
Partitioning total heart rate variability. Int J Cardiol (2009) 0.77
The BNP concentrations and exercise capacity assessment with cardiopulmonary stress test in patients after surgical repair of Fallot's tetralogy. Int J Cardiol (2005) 0.77
Obstructive sleep apnea and heart rate asymmetry microstructure during sleep. Clin Auton Res (2013) 0.77
Compensatory properties of heart rate asymmetry. J Electrocardiol (2012) 0.76
Cardiopulmonary exercise test in the evaluation of exercise capacity, arterial hypertension, and degree of descending aorta stenosis in adults after repair of coarctation of the aorta. Cardiol J (2007) 0.76
Doxazosin in the current treatment of hypertension. Expert Opin Pharmacother (2008) 0.76
Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation. Eur J Pharm Sci (2011) 0.76
Noninvasively assessed pulsatility of ascending aortic pressure waveform is associated with the presence of coronary artery narrowing. Heart Vessels (2008) 0.75
Early renal dysfunction after contrast media administration despite prophylactic hydration. Int J Cardiovasc Imaging (2013) 0.75
Letter regarding article by Wichterle et al, "prevalent low-frequency oscillation of heart rate: novel predictor of mortality after myocardial infarction". Circulation (2005) 0.75
[Does the treatment delay influence reperfusion efficacy and short- and long-term left ventricular function in patients with anterior myocardial infarction treated with primary coronary angioplasty?]. Pol Arch Med Wewn (2004) 0.75
[Twiddler syndrome: a rare complication of ICD implantation]. Kardiol Pol (2007) 0.75
Assessing sample entropy of physiological signals by the norm component matrix algorithm: application on muscular signals during isometric contraction. Conf Proc IEEE Eng Med Biol Soc (2013) 0.75
[Fascicular tachycardia - a rare case of ventricular tachycardia]. Kardiol Pol (2010) 0.75
Late proarrhythmia on sotalol therapy triggered by emotional stress. Kardiol Pol (2011) 0.75
The new generation is coming. Percutaneous implantation of the fully repositionable Lotus® aortic valve prosthesis: the first Polish experience. Kardiol Pol (2014) 0.75
[Cardiopulmonary exercise testing and cytokines in chronic heart failure. Comparison of patients with ischaemic and with dilated cardiomyopathy]. Pol Arch Med Wewn (2004) 0.75
[Ventricular tachycardia resistant to pharmacological and ablation therapy--a case report]. Kardiol Pol (2004) 0.75
Decreased large-artery stiffness in midluteal phase of the menstrual cycle in healthy women of reproductive age. Ginekol Pol (2014) 0.75
[Long-term effects of radiofrequency ablation of ventricular tachycardia originating from the aortic cusps]. Kardiol Pol (2005) 0.75
First Polish implantations of the smallest minimally invasive implantable loop recorder. Kardiol Pol (2015) 0.75
Fibrinogen and d-dimer in contrasting relation with measures of wave reflection and arterial stiffness. Scand J Clin Lab Invest (2012) 0.75
[Left ventricular remodelling and rebuilding of the infarcted area. Morphometric evaluation of the relationships between left ventricular mass, myocyte diameter, capillary density and fibrosis]. Pol Arch Med Wewn (2006) 0.75
The 64-slice computed tomography of a coronary artery fistula communicating with the right ventricle. Cardiol J (2008) 0.75
Adrenal pheochromocytoma associated with dramatic cyclic hemodynamic fluctuations. Int J Cardiol (2005) 0.75
Arterial structure and function in patients with acute coronary syndrome after 1‑year treatment. Pol Arch Intern Med (2017) 0.75
[Cardiopulmonary exercise test in the evaluation of exercise capacity in patients with Ebstein anomaly and patent ostium secundum atrial septal defect aged over 30 years]. Pol Merkur Lekarski (2006) 0.75
Arterial stiffness, body fat compartments, central hemodynamics, renal function and left atrial size. Scand J Clin Lab Invest (2013) 0.75
Renal morphology assessed by ultrasound in relation to central haemodynamics and body fat. Clin Exp Pharmacol Physiol (2013) 0.75
[Arterial stiffness in hypopituitary patients with life-long growth hormone deficiency]. Pol Arch Med Wewn (2007) 0.75
Oxygen uptake efficiency slope correlates with brain natriuretic peptide in patients with heart failure. Cardiol J (2010) 0.75
Hypertrophic cardiomyopathy and left atrial myxoma. Pol Arch Med Wewn (2014) 0.75
Reproducibility of the measurements of creatinine clearance in patients with a stable renal function. Int Urol Nephrol (2004) 0.75
Impaired glucose tolerance worsens exercise capacity and ventilatory response to exercise in patients with chronic heart failure. Kardiol Pol (2007) 0.75